These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23793003)

  • 1. Cost-effectiveness: the ménage à trois having a ratio with one denominator and one numerator.
    Serruys PW
    EuroIntervention; 2013 Jun; 9(2):173. PubMed ID: 23793003
    [No Abstract]   [Full Text] [Related]  

  • 2. Numbers needed to treat (lives!) and numbers needed to save (money).
    Ribichini F; Taggart D; Vassanelli C
    EuroIntervention; 2013 Jun; 9(2):175-7. PubMed ID: 23793004
    [No Abstract]   [Full Text] [Related]  

  • 3. New technology and the cost of health care.
    Beller GA
    J Nucl Cardiol; 2005; 12(5):515-7. PubMed ID: 16171708
    [No Abstract]   [Full Text] [Related]  

  • 4. Crunch time for clinical cardiology.
    Lewis RP
    Am Heart Hosp J; 2003; 1(1):104-6. PubMed ID: 15785184
    [No Abstract]   [Full Text] [Related]  

  • 5. Managed care in cardiology.
    Palank EA
    J Cardiovasc Manag; 1997; 8(1):18-20. PubMed ID: 10165391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real value: a strategy for interventional cardiologists to lead healthcare reform.
    Duffy PL
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):188-91. PubMed ID: 24497462
    [No Abstract]   [Full Text] [Related]  

  • 7. Tele-cardiology.
    Molefi M; Fortuin J; Wynchank S
    Cardiovasc J S Afr; 2006; 17(1):27-32. PubMed ID: 16547558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. President's page: A global opportunity to improve cardiovascular outcomes.
    Blankstein R; Nicol E; Bittencourt M; Rubinshtein R
    J Cardiovasc Comput Tomogr; 2020; 14(2):105-106. PubMed ID: 32107159
    [No Abstract]   [Full Text] [Related]  

  • 9. Most important papers in health costs, cost-effectiveness, and resource utilization.
    Dharmarajan K; Lampropulos J; Bikdeli B; Mody P; Gupta A
    Circ Cardiovasc Qual Outcomes; 2012 Mar; 5(2):e9-15. PubMed ID: 22438466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical economics and the assessment of value in cardiovascular medicine: Part I.
    Mark DB; Hlatky MA
    Circulation; 2002 Jul; 106(4):516-20. PubMed ID: 12135955
    [No Abstract]   [Full Text] [Related]  

  • 11. Perspectives and prospects for health system reform.
    Mayer JE; Dove JT
    Semin Thorac Cardiovasc Surg; 2009; 21(1):3-6. PubMed ID: 19632556
    [No Abstract]   [Full Text] [Related]  

  • 12. [Analysis of cost-effectiveness of simvastatin versus atorvastatin in the secondary prevention of cardiovascular events within the Brazilian public healthcare system].
    Araujo DV; Ribeiro de Souza CP; Bahia LR; Rey HC; Dos Santos Junior B; Tura BR; Berwanger O; Buehler AM; Silva MT
    Value Health; 2011; 14(5 Suppl 1):S29-32. PubMed ID: 21839894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conflict of interest-draining the swamp means confronting alligators.
    Wyse DG
    J Interv Card Electrophysiol; 2005 Jun; 13(1):5-7. PubMed ID: 15976972
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-Effectiveness Analysis of Cardiovascular Disease Treatment in Japan.
    Kodera S; Kiyosue A; Ando J; Akazawa H; Morita H; Watanabe M; Komuro I
    Int Heart J; 2017 Dec; 58(6):847-852. PubMed ID: 29151496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2013 American Society of Nuclear Cardiology / MedAxiom Nuclear Survey.
    J Nucl Cardiol; 2014 Apr; 21 Suppl 1():5-88. PubMed ID: 24619286
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolving models of cardiovascular practices.
    Itchhaporia D
    Rev Cardiovasc Med; 2010; 11(3):e150-2. PubMed ID: 21045767
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiology by the numbers and cost-containment.
    Knoebel SB
    Am J Cardiol; 1988 May; 61(13):1112-5. PubMed ID: 3364366
    [No Abstract]   [Full Text] [Related]  

  • 18. Value in Healthcare Special Issue.
    Ho PM
    Circ Cardiovasc Qual Outcomes; 2020 May; 13(5):e006817. PubMed ID: 32393126
    [No Abstract]   [Full Text] [Related]  

  • 19. HMO mandates doom risk contract for cardio network.
    Capitation Manag Rep; 2003 Feb; 10(2):17-20. PubMed ID: 12635481
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular medicine in difficult times of economic recession.
    Vardas PE
    Hellenic J Cardiol; 2009; 50(2):165. PubMed ID: 19329422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.